Is This Ultimate High‑Yield Stock Actually Going to $0?

Conagra’s 9.8% dividend yield stands out, but the article argues it reflects elevated risk rather than opportunity. Fiscal 2026 guidance implies adjusted EPS of $1.70-$1.85 versus $2.30 last year, after fiscal 2025 organic sales fell 2.9% and adjusted earnings dropped nearly 14%. The dividend is still covered at the low end of guidance, but leverage, weaker interest coverage, and recession risk could pressure the payout.

Analysis

The market is treating CAG’s yield like a bond substitute, but the more relevant framing is as a levered low-growth equity with a payout policy underwritten by operating stability that is no longer there. In packaged foods, weaker brand equity usually shows up first in price/mix decay, then in higher trade promotion intensity, and only later in headline volume losses; that sequence is exactly what can make apparent earnings coverage look safer than it is. The dividend is therefore less a source of support than a delayed catalyst: if margins fail to reaccelerate over the next 2-3 quarters, the equity can de-rate even if the payout is technically covered today.

The second-order winner is not a direct competitor so much as any operator with better brand pricing power, cleaner balance sheets, and more room to defend shelf space without sacrificing profitability. If consumer stress worsens, retailers will likely continue to favor faster-turning, higher-velocity staples, which hurts second-tier incumbents first because they need more promotions to hold facings. That dynamic can spill into private label as well: when branded leaders pull back on discounting, private label gains are usually strongest in the 6-12 month window, not immediately.

The key risk is that investors anchor on yield and miss balance-sheet optionality. If interest rates stay higher for longer, the cost of refinancing and the opportunity cost of capital remain a drag, making even modest earnings downgrades disproportionately harmful to equity value. A recession would not need to be severe to pressure the name; a mild consumer slowdown plus another leg of input-cost inflation could be enough to force a dividend reset narrative within two reporting cycles.

The contrarian view is that the market may already be pricing in a lot of this skepticism, which limits further downside unless guidance deteriorates again. That creates a tactical setup rather than a long-duration short: the better expression is to fade the yield chase on strength, not to structurally short the business at current levels. In other words, CAG looks like a value trap only if earnings revisions keep moving lower; if management merely stabilizes, the stock can bounce on short-covering, but that is a trade, not an investment case.

Key Decisions for Investors

• Avoid initiating new long CAG positions purely for yield; the cleaner setup is to wait for either a dividend-policy inflection or a hard guide-down that resets valuation over the next 1-2 quarters.
• For existing consumer staples exposure, rotate toward higher-quality branded peers and away from levered laggards like CAG over the next 30-60 days; the risk/reward favors balance-sheet strength over headline yield.
• Consider a pair trade: long a higher-quality staples name with pricing power vs. short CAG into earnings or guidance events, targeting 6-10% relative performance over 3-6 months if revisions diverge.
• If CAG rallies on yield-chasing flows, use that strength to buy puts or construct a bearish put spread 3-6 months out; the asymmetric risk is another earnings miss or dividend-risk headline driving a fast multiple reset.
• For income-focused portfolios, prefer short-duration bonds or defensives with lower payout risk over CAG; the 9.8% yield is not compelling enough compensation for a potential 15-25% equity drawdown if the market prices a cut.